Loading...
Loading...
Illumina, Inc.
ILMN today announced the availability of its
Phasing Analysis Service, provided by the company's FastTrack Services
lab through the Illumina Genome Network (IGN). The new sample-to-answer
service delivers human whole-genome phase information, empowering gene
mapping studies with a more comprehensive view of genomic variation.
With phase data, researchers can better understand the effect of
genotype on phenotype and variant interaction within a gene.
Conventionally, whole-genome sequencing generates a single consensus
sequence without assigning variants to specific homologous
chromosomes. Phase information, however, can identify segments of
connected variants, facilitating ancestry determination in population
studies. Further, in instances where two potentially deleterious
variants occur in a gene, knowing how these
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in